NASDAQ:ATEC - Alphatec Stock Price, Price Target & More

$4.02 +0.16 (+4.15 %)
(As of 04/24/2018 08:48 AM ET)
Previous Close$3.86
Today's Range$3.90 - $4.21
52-Week Range$1.58 - $4.27
Volume250,800 shs
Average Volume90,491 shs
Market Capitalization$98.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.25

About Alphatec (NASDAQ:ATEC)

Alphatec logoAlphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, and Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody Systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Debt-to-Equity Ratio-1.42%
Current Ratio2.23%
Quick Ratio1.32%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$101.74 million
Price / Sales1.01
Cash Flow$0.1542 per share
Price / Cash26.07
Book Value($1.34) per share
Price / Book-3.00

Profitability

EPS (Most Recent Fiscal Year)($0.36)
Net Income$-2,290,000.00
Net Margins-2.25%
Return on EquityN/A
Return on Assets-6.31%

Miscellaneous

Employees138
Outstanding Shares25,550,000

How to Become a New Pot Stock Millionaire

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) posted its earnings results on Thursday, March, 8th. The medical technology company reported $0.39 EPS for the quarter, topping the consensus estimate of ($0.21) by $0.60. The medical technology company earned $26.28 million during the quarter. View Alphatec's Earnings History.

What price target have analysts set for ATEC?

2 analysts have issued 12-month price targets for Alphatec's stock. Their forecasts range from $4.00 to $7.00. On average, they anticipate Alphatec's share price to reach $5.50 in the next year. View Analyst Ratings for Alphatec.

Who are some of Alphatec's key competitors?

Who are Alphatec's key executives?

Alphatec's management team includes the folowing people:
  • Mr. Terry M. Rich, Pres, COO & Director (Age 50)
  • Mr. Patrick S. Miles, CEO & Exec. Chairman (Age 52)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 49)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture and Gen. Counsel (Age 54)
  • Mr. Stephen A. Lubischer, VP of Sales (Age 55)

Has Alphatec been receiving favorable news coverage?

Media coverage about ATEC stock has trended somewhat positive on Tuesday, Accern reports. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alphatec earned a coverage optimism score of 0.13 on Accern's scale. They also assigned news headlines about the medical technology company an impact score of 49.30 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include ARMISTICE CAPITAL, LLC (9.99%). Company insiders that own Alphatec stock include Brian Snider, Jeffrey G Black, John Foster, Leslie H Cross and Terry Rich. View Institutional Ownership Trends for Alphatec.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $4.02.

How big of a company is Alphatec?

Alphatec has a market capitalization of $98.62 million and generates $101.74 million in revenue each year. The medical technology company earns $-2,290,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Alphatec employs 138 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]


MarketBeat Community Rating for Alphatec (ATEC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  128 (Vote Outperform)
Underperform Votes:  127 (Vote Underperform)
Total Votes:  255
MarketBeat's community ratings are surveys of what our community members think about Alphatec and other stocks. Vote "Outperform" if you believe ATEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATEC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Alphatec (NASDAQ:ATEC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Alphatec in the last 12 months. Their average twelve-month price target is $5.50, suggesting that the stock has a possible upside of 36.82%. The high price target for ATEC is $7.00 and the low price target for ATEC is $4.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.50$5.50$5.50$5.50
Price Target Upside: 36.82% upside66.67% upside83.95% upside52.35% upside

Alphatec (NASDAQ:ATEC) Consensus Price Target History

Price Target History for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ:ATEC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/13/2018HC WainwrightSet Price TargetBuy$4.00HighView Rating Details
10/16/2017Lake Street CapitalInitiated CoverageBuy -> Buy$7.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Alphatec (NASDAQ:ATEC) Earnings History and Estimates Chart

Earnings by Quarter for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ:ATEC) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.46 EPS
Next Year EPS Consensus Estimate: $-0.26 EPS

Alphatec (NASDAQ ATEC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018Q4 2017($0.21)$0.39$26.28 millionViewN/AView Earnings Details
11/9/2017Q3 2017($0.15)($0.22)$23.10 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.32)$24.38 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.60)$27.98 millionViewN/AView Earnings Details
3/15/2017Q4 2016($1.21)$27.09 millionViewN/AView Earnings Details
11/9/2016Q3 2016($1.18)$26.71 millionViewN/AView Earnings Details
8/9/2016Q2 2016($0.60)$43.79 millionViewN/AView Earnings Details
5/5/2016Q1 2016($0.84)$44.76 millionViewN/AView Earnings Details
3/15/2016Q415($0.05)($0.03)$50.01 million$47.00 millionViewN/AView Earnings Details
8/4/2015Q2($0.02)($0.04)$51.90 million$46.60 millionViewListenView Earnings Details
4/30/2015Q1 2015($0.24)($0.36)$49.60 million$48.65 millionViewN/AView Earnings Details
2/26/2015Q414($0.01)($0.03)$54.81 million$53.60 millionViewListenView Earnings Details
10/30/2014Q3 2014$0.12($0.24)$52.40 million$51.01 millionViewN/AView Earnings Details
7/31/2014Q314($0.01)($0.02)$52.10 million$51.00 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.03)$0.01$50.65 million$49.17 millionViewN/AView Earnings Details
3/17/2014Q413($0.02)($0.02)$52.50 million$53.10 millionViewN/AView Earnings Details
11/7/2013Q3 2013($0.24)$0.12$47.85 million$50.20 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.24)($0.12)$49.50 million$51.02 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.36)($0.36)$50.51 million$50.44 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.12)($0.12)ViewN/AView Earnings Details
11/5/2012Q3 2012($0.12)$0.12ViewN/AView Earnings Details
8/7/2012Q2 2012($0.12)($0.12)ViewN/AView Earnings Details
5/8/2012Q1 2012($0.24)($0.17)ViewN/AView Earnings Details
2/28/2012Q4 2011($0.71)ViewN/AView Earnings Details
8/4/2011Q2 2011($0.24)ViewN/AView Earnings Details
5/4/2011Q1 2011$0.01ViewN/AView Earnings Details
2/24/2011Q4 2010($0.12)($0.20)ViewN/AView Earnings Details
11/8/2010Q3 2010($0.12)($0.10)ViewN/AView Earnings Details
8/5/2010Q2 2010$0.12($0.05)ViewN/AView Earnings Details
5/10/2010Q1 2010($0.12)($0.05)ViewN/AView Earnings Details
2/23/2010Q4 2009($0.12)$0.08ViewN/AView Earnings Details
11/9/2009Q3 2009($0.24)($0.24)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.48)($1.61)ViewN/AView Earnings Details
5/4/2009Q1 2009($0.60)($0.79)ViewN/AView Earnings Details
3/2/2009Q4 2008($0.72)($1.31)ViewN/AView Earnings Details
11/3/2008Q3 2008($0.72)($1.25)ViewN/AView Earnings Details
8/4/2008Q2 2008($0.84)($0.94)ViewN/AView Earnings Details
4/24/2008Q1 2008($0.48)($0.88)ViewN/AView Earnings Details
2/13/2008Q4 2007($0.96)($0.65)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Alphatec (NASDAQ:ATEC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Alphatec (NASDAQ ATEC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 23.60%
Institutional Ownership Percentage: 11.95%
Insider Trading History for Alphatec (NASDAQ:ATEC)
Institutional Ownership by Quarter for Alphatec (NASDAQ:ATEC)

Alphatec (NASDAQ ATEC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/25/2017Terry RichCEOBuy2,500$1.99$4,975.00207,958View SEC Filing  
8/17/2017Jeffrey G. BlackVPBuy5,000$1.80$9,000.00View SEC Filing  
8/16/2017Jeffrey G BlackVPBuy4,000$1.75$7,000.0079,000View SEC Filing  
8/15/2017Brian SniderEVPBuy3,000$1.69$5,070.0078,000View SEC Filing  
8/15/2017Terry RichCEOBuy2,958$1.69$4,999.02205,458View SEC Filing  
12/16/2016Leslie H CrossDirectorBuy15,000$4.25$63,750.0065,443View SEC Filing  
12/16/2016Terry RichCEOBuy2,500$4.26$10,650.00202,500View SEC Filing  
11/30/2016John FosterMajor ShareholderSell17,533$5.26$92,223.58View SEC Filing  
5/20/2015Mitsuo AsaiInsiderBuy10,000$1.39$13,900.00View SEC Filing  
12/10/2014Mitsuo AsaiInsiderBuy2,251$1.30$2,926.30View SEC Filing  
12/9/2014Mitsuo AsaiInsiderBuy7,749$1.30$10,073.70View SEC Filing  
5/14/2014James CorbettCEOBuy25,000$1.35$33,750.00275,000View SEC Filing  
5/14/2014Leslie CrossChairmanBuy10,000$1.35$13,500.00514,770View SEC Filing  
5/13/2014Leslie CrossChairmanBuy25,000$1.33$33,250.00504,770View SEC Filing  
11/30/2012Leslie H CrossCEOBuy20,000$1.60$32,000.00View SEC Filing  
11/29/2012Leslie H CrossCEOBuy10,819$1.55$16,769.45View SEC Filing  
11/26/2012Leslie H CrossCEOBuy20,000$1.56$31,200.00View SEC Filing  
11/21/2012Leslie H CrossCEOBuy10,000$1.55$15,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Alphatec (NASDAQ ATEC) News Headlines

Source:
DateHeadline
Contrasting Alphatec (ATEC) and Its RivalsContrasting Alphatec (ATEC) and Its Rivals
www.americanbankingnews.com - April 15 at 3:11 AM
HC Wainwright Initiates Coverage on Alphatec (ATEC)HC Wainwright Initiates Coverage on Alphatec (ATEC)
www.americanbankingnews.com - April 10 at 5:38 PM
Lake Street Capital Begins Coverage on Alphatec (ATEC)Lake Street Capital Begins Coverage on Alphatec (ATEC)
www.americanbankingnews.com - April 7 at 9:11 AM
Analyzing Alphatec (ATEC) and Its PeersAnalyzing Alphatec (ATEC) and Its Peers
www.americanbankingnews.com - April 2 at 7:12 PM
Active-Investors: Wired News - Haemonetics Received 510(k) Clearance from FDA of NexSys PCS Embedded SoftwareActive-Investors: Wired News - Haemonetics Received 510(k) Clearance from FDA of NexSys PCS Embedded Software
www.finanznachrichten.de - April 2 at 9:57 AM
Wired News – Haemonetics Received 510(k) Clearance from FDA of NexSys PCS(TM) Embedded SoftwareWired News – Haemonetics Received 510(k) Clearance from FDA of NexSys PCS(TM) Embedded Software
finance.yahoo.com - April 2 at 9:57 AM
 Alphatec Holdings, Inc. (ATEC) Given $5.50 Consensus Target Price by Analysts Alphatec Holdings, Inc. (ATEC) Given $5.50 Consensus Target Price by Analysts
www.americanbankingnews.com - March 31 at 3:36 PM
Critical Comparison: Alphatec (ATEC) vs. Its RivalsCritical Comparison: Alphatec (ATEC) vs. Its Rivals
www.americanbankingnews.com - March 22 at 7:12 PM
Alphatec Spine Announces Participation at the Oppenheimer & Co. Inc. 28th Annual Healthcare ConferenceAlphatec Spine Announces Participation at the Oppenheimer & Co. Inc. 28th Annual Healthcare Conference
finance.yahoo.com - March 19 at 9:41 AM
HC Wainwright Reiterates "$4.00" Price Target for Alphatec (ATEC)HC Wainwright Reiterates "$4.00" Price Target for Alphatec (ATEC)
www.americanbankingnews.com - March 18 at 10:24 AM
Edited Transcript of ATEC earnings conference call or presentation 8-Mar-18 10:30pm GMTEdited Transcript of ATEC earnings conference call or presentation 8-Mar-18 10:30pm GMT
finance.yahoo.com - March 18 at 9:24 AM
Alphatec (ATEC) Rating Lowered to Sell at Zacks Investment ResearchAlphatec (ATEC) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 15 at 6:00 PM
Alphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership AppointmentsAlphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments
finance.yahoo.com - March 9 at 10:02 AM
Alphatec posts 4Q profitAlphatec posts 4Q profit
finance.yahoo.com - March 9 at 10:02 AM
Alphatec Holdingss Earnings PreviewAlphatec Holdings's Earnings Preview
finance.yahoo.com - March 8 at 5:19 PM
Alphatec Spine Reports Fourth Quarter and Full Year 2017 Financial ResultsAlphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 8 at 5:19 PM
 Brokerages Anticipate Alphatec Holdings, Inc. (ATEC) to Announce -$0.21 EPS Brokerages Anticipate Alphatec Holdings, Inc. (ATEC) to Announce -$0.21 EPS
www.americanbankingnews.com - January 24 at 3:26 PM
Alphatec (ATEC) Raised to "Hold" at Zacks Investment ResearchAlphatec (ATEC) Raised to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 23 at 6:44 PM
BRIEF-Patrick Miles Reports 9.1 Pct Stake In Alphatec Holdings As Of Dec 28‍BRIEF-Patrick Miles Reports 9.1 Pct Stake In Alphatec Holdings As Of Dec 28‍
www.reuters.com - January 9 at 11:04 AM
Alphatec Holdings, Inc. (ATEC) Sees Significant Drop in Short InterestAlphatec Holdings, Inc. (ATEC) Sees Significant Drop in Short Interest
www.americanbankingnews.com - January 1 at 3:07 AM
 Alphatec Holdings, Inc. (ATEC) Given $4.33 Average Price Target by Analysts Alphatec Holdings, Inc. (ATEC) Given $4.33 Average Price Target by Analysts
www.americanbankingnews.com - December 26 at 4:07 PM
Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017Alphatec Holdings, Inc. :ATEC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017
finance.yahoo.com - December 22 at 11:27 AM
Alphatec (ATEC) Downgraded by ValuEngine to "Strong Sell"Alphatec (ATEC) Downgraded by ValuEngine to "Strong Sell"
www.americanbankingnews.com - December 3 at 10:50 PM
HC Wainwright Reaffirms "Buy" Rating for Alphatec Holdings, Inc. (ATEC)HC Wainwright Reaffirms "Buy" Rating for Alphatec Holdings, Inc. (ATEC)
www.americanbankingnews.com - November 22 at 4:26 PM
 Analysts Set $4.33 Price Target for Alphatec Holdings, Inc. (ATEC) Analysts Set $4.33 Price Target for Alphatec Holdings, Inc. (ATEC)
www.americanbankingnews.com - November 18 at 3:37 AM
Alphatec Holdings (ATEC) CEO Terry Rich on Q3 2017 Results - Earnings Call TranscriptAlphatec Holdings' (ATEC) CEO Terry Rich on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:47 AM
Alphatec Holdings, Inc. to Host Earnings CallAlphatec Holdings, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 1:40 PM
Edited Transcript of ATEC earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of ATEC earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 1:40 PM
Investor Network: Alphatec Holdings, Inc. to Host Earnings CallInvestor Network: Alphatec Holdings, Inc. to Host Earnings Call
www.finanznachrichten.de - November 9 at 5:20 PM
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial ResultsAlphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
www.thestreet.com - November 9 at 5:20 PM
BRIEF-Alphatec Holdings Inc posts Q3 loss per share ‍$0.23BRIEF-Alphatec Holdings Inc posts Q3 loss per share ‍$0.23
www.reuters.com - November 9 at 5:20 PM
Spine Biologics Market Expected To Be Worth US$ 2.5 Billion Globally By 2022Spine Biologics Market Expected To Be Worth US$ 2.5 Billion Globally By 2022
www.marketwatch.com - November 7 at 10:58 PM
Global Lumbar Spine Fusion Sales Market will Rise at a CAGR of 4.9% by 2022Global Lumbar Spine Fusion Sales Market will Rise at a CAGR of 4.9% by 2022
www.marketwatch.com - October 30 at 10:12 PM
Alphatec Holdings, Inc. (ATEC) Sees Large Increase in Short InterestAlphatec Holdings, Inc. (ATEC) Sees Large Increase in Short Interest
www.americanbankingnews.com - October 28 at 1:26 AM
Alphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate UpdatesAlphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates
globenewswire.com - October 25 at 3:59 AM
BRIEF-Alphatec Holdings files for mixed shelf of up to $100 mlnBRIEF-Alphatec Holdings files for mixed shelf of up to $100 mln
www.reuters.com - October 25 at 3:58 AM
Alphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate UpdatesAlphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates
finance.yahoo.com - October 24 at 5:57 PM
Alphatec Denounces “Baseless” NuVasive ComplaintAlphatec Denounces “Baseless” NuVasive Complaint
finance.yahoo.com - October 11 at 5:38 PM
NuVasive (NUVA) Files Lawsuit Against Former Vice ChairmanNuVasive (NUVA) Files Lawsuit Against Former Vice Chairman
www.streetinsider.com - October 11 at 3:28 AM
NuVasive sues former executive who moved to rival AlphatecNuVasive sues former executive who moved to rival Alphatec
finance.yahoo.com - October 10 at 10:27 PM
Nuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders InterestsNuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders' Interests
finance.yahoo.com - October 10 at 5:26 PM
Head-To-Head Comparison: Alphatec Holdings (ATEC) vs. Sequenom (SQNM)Head-To-Head Comparison: Alphatec Holdings (ATEC) vs. Sequenom (SQNM)
www.americanbankingnews.com - October 6 at 12:12 PM
Varex Imaging (VREX) and Alphatec Holdings (ATEC) Head to Head ReviewVarex Imaging (VREX) and Alphatec Holdings (ATEC) Head to Head Review
www.americanbankingnews.com - October 4 at 12:28 PM
Should You Worry About Alphatec Holdings Inc (ATEC) Cash Runway?Should You Worry About Alphatec Holdings Inc (ATEC) Cash Runway?
finance.yahoo.com - October 3 at 3:52 PM
Varex Imaging (VREX) & Alphatec Holdings (ATEC) Critical ComparisonVarex Imaging (VREX) & Alphatec Holdings (ATEC) Critical Comparison
www.americanbankingnews.com - October 2 at 8:36 PM
Mid-Day Market Update: Crude Oil Down Over 2%; Endocyte Shares Spike HigherMid-Day Market Update: Crude Oil Down Over 2%; Endocyte Shares Spike Higher
www.nasdaq.com - October 2 at 4:01 PM
BRIEF-Alphatec announces additional spine-experienced leadership appointmentsBRIEF-Alphatec announces additional spine-experienced leadership appointments
www.reuters.com - October 2 at 4:01 PM
Alphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership AppointmentsAlphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership Appointments
globenewswire.com - October 2 at 4:01 PM
Critical Survey: Varex Imaging (VREX) & Alphatec Holdings (ATEC)Critical Survey: Varex Imaging (VREX) & Alphatec Holdings (ATEC)
www.americanbankingnews.com - September 24 at 10:20 AM
Head-To-Head Survey: Sequenom (SQNM) vs. Alphatec Holdings (ATEC)Head-To-Head Survey: Sequenom (SQNM) vs. Alphatec Holdings (ATEC)
www.americanbankingnews.com - September 20 at 2:22 PM

SEC Filings

Alphatec (NASDAQ:ATEC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Alphatec (NASDAQ:ATEC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Alphatec (NASDAQ ATEC) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.